Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Zecuity (NP101) in acute migraine
NCT00806546Phase 3Completed
- Sponsor
- NuPathe Inc.
- Start
- Feb 2009
- Primary completion
- May 2011
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Zecuity in migraine, sponsored by NuPathe Inc.. Started Feb 2009; status: completed.
02
Drugs
Zecuity
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00806546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806546.